Glomerular Filtration Rate-Estimating Equations During Use of Direct Oral Anticoagulants in Elderly Patients
NCT02964546 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 116
Last updated 2021-10-20
Summary
Atrial fibrillation in the elderly is a complex condition due to the high number of frequently associated comorbidities such kidney disease. Direct oral anticoagulants (dabigatran, rivaroxaban and apixaban) are indicated for preventing thromboembolic events but renal function should be closely monitored for this age group when these drugs are used. Dosing recommendations for prevention of stroke are based on renal clearance of creatinine (ClCr) estimated using the Cockcroft-Gault formula. It is well known that ClCr estimates predict a steeper decline with advancing age than Glomerular Filtration Rate (GFR) estimates. This raises the possibility that substitution of commonly reported GFR for estimated CrCl could result in different plasmatic concentrations of oral direct anticoagulants. The aim of this study was to compare estimates of ClCr and GFR and determine the impact on the plasmatic concentration of these drugs in elderly patients with non-valvular atrial fibrillation.
Conditions
- Atrial Fibrillation
- Elderly Patients
- Chronic Kidney Disease
Interventions
- OTHER
-
Blood sample
2 additional tubes of blood samples are collected during a blood sample realized for the patient's care
Sponsors & Collaborators
-
University Hospital, Montpellier
lead OTHER
Eligibility
- Min Age
- 65 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-08
- Primary Completion
- 2017-11-20
- Completion
- 2018-12-07
Countries
- France
Study Locations
More Related Trials
-
Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty
NCT04878497 ·Status: UNKNOWN
-
Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi
NCT03926780 ·Status: COMPLETED ·Phase: PHASE3
-
Thrombosis and Haemorrhage in Chronic Hemodialysis Patients
NCT02897258 ·Status: COMPLETED
-
Study of Clinical and Laboratory Variables Associated With a Direct Oral Anticoagulant Bioassay Higher Among Those Aged Over 75 Years
NCT02894450 ·Status: COMPLETED
-
A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients
NCT02607111 ·Status: COMPLETED ·Phase: PHASE4
-
Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
NCT02286414 ·Status: COMPLETED
-
Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin
NCT05150314 ·Status: UNKNOWN
-
Study of Apixaban in Patients Receiving Hemodiafiltration
NCT04952792 ·Status: COMPLETED ·Phase: PHASE2
-
Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies
NCT03157154 ·Status: COMPLETED
-
Sources of the Variability of the Response to Fluindione in Elderly Patients (PREPA)
NCT00313469 ·Status: COMPLETED
-
Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function
NCT00264693 ·Status: COMPLETED
-
A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark
NCT02591732 ·Status: COMPLETED
-
Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment
NCT04096547 ·Status: UNKNOWN
-
Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)
NCT02906527 ·Status: UNKNOWN
-
Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
NCT02592980 ·Status: UNKNOWN ·Phase: PHASE4
-
Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral Anticoagulants
NCT02969746 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.
NCT06795698 ·Status: COMPLETED ·Phase: PHASE2
-
Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis
NCT00277394 ·Status: COMPLETED ·Phase: PHASE4
-
AntiCoagulation Tracking InterVention and Evaluation
NCT04059965 ·Status: WITHDRAWN ·Phase: NA
-
A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients.
NCT03715725 ·Status: TERMINATED
-
Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study
NCT03456648 ·Status: COMPLETED ·Phase: PHASE2
-
Weekly Monitoring Strategy of Capillary INR Versus Monthly Monitoring Strategy of Venous INR in Elderly Patients in a Nursing Home.
NCT05561244 ·Status: TERMINATED ·Phase: NA
-
Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients.
NCT01970280 ·Status: UNKNOWN ·Phase: PHASE4
-
Haemodialysis Alters Hypercoagulability of Blood in Dialysis Patients
NCT07098676 ·Status: ENROLLING_BY_INVITATION
-
Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels
NCT04539301 ·Status: RECRUITING